Insights from 2024 ESGO Annual Meeting
ESGO 2024 Insights: "The Movie Trial - Safety & Efficacy of Durvalumab + Tremelimumab + Metronomic Oral Vinorelbine in Pts With Recurrent/Metastatic Cervical Cancer"
Comments 0
Login to view comments.
Click here to Login
